NightHawk Biosciences (NYSE:NHWK) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS

NightHawk Biosciences (NYSE:NHWK – Get Free Report) released its earnings results on Monday. The biopharmaceutical company reported ($0.38) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.03), reports. The company had revenue of $0.72 million for the quarter, compared to analysts’ expectations of $1.60 million. NightHawk Biosciences had a negative return on […]

Related Keywords

,Pricet Rowe Associates Inc ,Nighthawk Biosciences Inc ,Heat Biologics Inc ,Blackrock Inc ,Dimensional Fund Advisors ,Vanguard Group Inc ,Nighthawk Biosciences Company Profile ,Nighthawk Biosciences ,Get Free Report ,Hawk Biosciences ,Street Corp ,Fund Advisors ,Pricet Rowe Associates ,Heat Biologics ,Nighthawk Biosciences Daily ,Nyse Nhwk ,Nhwk ,Medical ,Earnings ,